Selective Media for Bifidobacteria

Jvo Siegrist

AnalytiX

Volume 9 Article 4

ivo.siegrist@sial.com

Sigma-Aldrich® supplies media for the selective isolation, identifi cation and enumeration of bifidobacteria like Bifidobacterium longum, infantis and brevi which are used for quality control in the manufacture of dairy products.

Bifi dobacteria are Gram-positive, non-motile, rod-shaped and often branched anaerobic bacteria. They have a positive effect on the immune system and control intestinal pH. Bifi dobacteria produce bacteriocins and bacteriocin-like inhibitory compounds which inhibit the growth of other bacteria.

B.longum is the best-characterised species in the genus Bifi dobacterium. It is able to utilise a broad range of substrates for energy, such as plant polymers, glycoproteins and glyconjugates, as well as having specialised proteins for the catabolism of oligosaccharides.

Bifi dobacteria also have a unique hexose metaboliam called the bifi d shunt. The key enzyme, fructose-6-phosphate phosphoketolase, is not found in any other gram-positive intestinal bacteria and therefore provides an ideal target for a diagnostic test.

In adult’s intestine, only 3–6 % of the faecal fl ora is composed of bifi dobacteria while in breast-fed infants bifi dobacteria can be up to 90 %. With increasing age the number of bifi dobacteria decrease. It was observed that babies and adults with lower numbers of bifi dobacteria have a higher risk for diarrhoea and allergies. For this reason bifi dobacterium are added as a probiotic supplement to infant formulas, drinks, yoghurts and a lot of other products.

Because of the wide use of bifi dus, we developed Bifi dobacteria Selective Media (BSM), available as an agar or a broth, for standard for quality control. This allows for easy and fast quality control of yoghurt made with bifi dus and can be used to control the count of bifi dus bacteria.

Bifidobacteria grow very well on this medium whilst Lactobacillus and Streptococcus strains are inhibited. Bifidobacterium colonies grow within 24– 48 hours (occasionally up to three days because of the highly selective conditions). The Bifidobacterium colonies are purplebrown and therefore easy to differentiate from other organisms.

yoghurt

Figure 1.Yoghurt sample cultured on BSM Agar. Bifidobacteria appears as purplebrown colonies

In a Swiss governmental evaluation study for the enumeration of bifi dobacteria in sour milk products, the traditional method was compared to Wilkins-Chalgren Agar with 100 mg/l mupirocine and BSM Agar. The traditional method gave significant differences while Wilkins-Chalgren Agar and BSM Agar showed similar results without any signifi cant differences. The study remarked: “On the BSM Agar the bifi dobacteria forms purple-brown colonies which made the enumeration easy”.

Materials
Loading

References

1.
Mikkelsen LL, Bendixen C, Jakobsen M, Jensen BB. 2003. Enumeration of Bifidobacteria in Gastrointestinal Samples from Piglets. AEM. 69(1):654-658. http://dx.doi.org/10.1128/aem.69.1.654-658.2003
2.
Rada V, Petr J. 2000. A new selective medium for the isolation of glucose non-fermenting bifidobacteria from hen caeca. Journal of Microbiological Methods. 43(2):127-132. http://dx.doi.org/10.1016/s0167-7012(00)00205-0
3.
Grand M, K?ffer M, Baumgartner A. 2003. Quantitative analysis and molecular identification of bifidobacteria strains in probiotic milk products. European Food Research and Technology. 217(1):90-92. http://dx.doi.org/10.1007/s00217-003-0711-6
4.
Rada V, Koc J. 2000. The use of mupirocin for selective enumeration of bifidobacteria in fermented milk products Milchwissenschaft. 55(2):65-67.
5.
Bundesamt für Gesundheit: Schweizerisches Lebensmittelbuch (SLMB): Kapitel 56, «Mikrobiologie» Neuausgabe 2000, Stand 2004.
6.
Horwitz W. 1995. Protocol for the design, conduct and interpretation of method-performance studies Revised 1994 (Technical Report) . International union of pure and applied chemistry.

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.